The expanding demand for specific immunological research and therapeutic development has spurred significant improvements in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using multiple expression methods, including bacterial hosts, mammalian cell lines, and in